Showing 3601-3610 of 19355 results for "".
How NEMLUVIO® Works
https://reachmd.com/programs/nemluvio-peer-network/how-nemluvio-works/37226/Learn how NEMLUVIO® works to directly block IL-31RA from Dr Peter Lio, a leading dermatologist, with extensive experience in treating neuroimmune skin diseases.Clinical Decision Making for HER2 Low Metastatic Breast Cancer
https://reachmd.com/programs/medical-industry-feature/clinical-decision-making-for-her2-low-metastatic-breast-cancer/24198/Reinforcing the value of biomarker testing to inform clinical decisions for HER2 low metastatic breast cancer patients.CKD-aP Treatment Tool Kit
https://reachmd.com/programs/cme/ckd-ap-treatment-tool-kit/36297/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
https://reachmd.com/programs/cme/tbd/36194/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Remission: Can You Prove It?
https://reachmd.com/programs/cme/remission-can-you-prove-it/51486/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
https://reachmd.com/programs/cme/living-with-systemic-mastocytosis-bridging-clinical-decisions-and-patient-realities/54389/Join us to explore the disease burden of systemic mastocytosis, evidence-based personalized care, and using multidisciplinary strategies to improve outcomes.Rethinking Disease Monitoring in Primary Biliary Cholangitis
https://reachmd.com/programs/gi-insights/rethinking-disease-monitoring-primary-biliary-cholangitis/54679/To effectively care for patients with primary biliary cholangitis (PBC), we may have to look beyond single data points to understand how the disease is truly progressing. By combining biomarkers with tools like elastography and patient-reported insights, we can take a more complete and proactive appIs CKD-aP Hiding in Your Dialysis Center?
https://reachmd.com/programs/cme/is-ckd-ap-hiding-in-your-dialysis-center/36299/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Future Directions in Managing Hyperkalemia in CKD and HF
https://reachmd.com/programs/cme/tbd/37676/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
https://reachmd.com/programs/cme/tbd/37675/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.